Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hussein Abdul-Hassan Tawbi, Peter A. J. Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid, Michael B. Atkins, Karl D. Lewis, Reena Parada Thomas, John A. Glaspy, Sekwon Jang, Alain Patrick Algazi, Nikhil I. Khushalani, Michael A. Postow, Anna C. Pavlick, Marc S. Ernstoff, David A. Reardon, Agnes Balogh, Jasmine I. Rizzo, Kim Allyson Margolin
Institutions: The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Dana-Farber Cancer Institute, University of Michigan, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Angeles Clinic and Research Institute, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of Colorado Cancer Center, Stanford Medicine, Stanford University, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Virginia Commonwealth University, University of California, San Francisco, Memorial Sloan Kettering Cancer Center, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Roswell Park Comprehensive Cancer Center, Bristol-Myers Squibb (United States), City Of Hope National Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2946844252